Sector Update: Healthcare Shares Flat Pre-Market; Clovis Sinks 2% on Pricing Public Offering


Shutterstock photo

Healthcare stocks:

JNJ: -0.18%

PFE: flat

ABT: flat

MRK: flat

AMGN: flat

Healthcare shares are flat in pre-market trade. Shares of Clovis Oncology Inc. ( CLVS ) are down 1.6% at $58.00 in pre-market trade as the company announces the pricing of an underwritten public offering of two million shares of its common stock at a price to the public of $57.50 per share.

And, the Medicines Company ( MDCO ) said it has acquired Rempex Pharmaceuticals, Inc., adding a range of antibiotics to treat drug resistant gram-negative bacteria to its infectious diseases portfolio.

The company will pay $140 million upfront, with a further $214 million in milestone payments and commercial milestone payments of $120 million.

Finally, Ambit Biosciences ( AMBI ) is down nearly 34% at $8.50 a share after saying it does not plan on submitting a new drug application for accelerated approval of it quizartinib drug candidate based on the Phase II and Phase IIb clinical testing of the prospective treatment for acute myeloid leukemia.

Following discussions with the U.S. Food and Drug Administration, AMBI said it plans to move forward with Phase III testing of quizartinib in leukemia patients who have relapsed or refractory to prior treatments.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing , Commodities
More Headlines for: AMBI , CLVS , MDCO

More from MT Newswires


MT Newswires

MT Newswires

Market News, Commodities
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by